Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

Rhea-AI Summary

Artelo Biosciences (NASDAQ: ARTL) announced its participation in the H.C. Wainwright BioConnect 2021 Conference, scheduled for January 11-14, 2021. The presentation will be available on-demand starting January 11 at 6:00 a.m. EDT and accessible for 90 days. Artelo is focused on developing therapeutics that modulate the endocannabinoid system to address unmet medical needs in conditions such as cancer, PTSD, and pain. The company is based in San Diego and is advancing a portfolio of product candidates aimed at various diseases.

LA JOLLA, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021.

A webcast of Artelo's presentation will be available on-demand as of 6:00 a.m. EDT, Monday, January 11, 2021 and will be accessible for 90 days. The webcast can be accessed here and the investor relations section of Artelo's website at https://ir.artelobio.com/.

About Artelo Biosciences

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting endogenous signaling pathways including the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, PTSD, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. More information is available at www.artelobio.com and Twitter: @ArteloBio.

Investor Relations Contact:
Crescendo Communications, LLC
Tel: 212-671-1020
Email: ARTL@crescendo-ir.com

FAQ

When will Artelo Biosciences present at the H.C. Wainwright BioConnect 2021 Conference?

Artelo Biosciences will present at the H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021.

How can I access Artelo's presentation from the H.C. Wainwright BioConnect 2021 Conference?

Artelo's presentation can be accessed on-demand starting January 11 at 6:00 a.m. EDT for 90 days via their website.

What therapeutics is Artelo Biosciences developing?

Artelo is developing therapeutics targeting the endocannabinoid system to address conditions like cancer, PTSD, and pain.

Where is Artelo Biosciences based?

Artelo Biosciences is based in San Diego.

What is the stock symbol for Artelo Biosciences?

The stock symbol for Artelo Biosciences is ARTL.